Assessment by molecular dynamics simulations of the structural determinants of DNA-binding specificity for transcription factor Sp1

Journal of Molecular Biology

Volumn 328, Issue 1, 2003, Pages 9-32

  Marco, Esther ^a   García Nieto, Raquel ^a   Gago, Federico ^a  

^a UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

EGR1 Zif268 Krox 24 NGFI A; Molecular dynamics simulations; Sp1; Transcription factors; Zinc fingers

Indexed keywords

DNA; EARLY GROWTH RESPONSE FACTOR 1; MULTIDRUG RESISTANCE PROTEIN 1; OLIGONUCLEOTIDE; TRANSCRIPTION FACTOR SP1; WATER; ZINC FINGER PROTEIN;

ACCURACY; ARTICLE; BINDING SITE; COMPARATIVE STUDY; DNA PROTEIN COMPLEX; GENE; MOLECULAR DYNAMICS; MOLECULAR MODEL; MOLECULAR RECOGNITION; PREDICTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN STABILITY; VALIDATION PROCESS; WT1 GENE;

EID: 0037453219     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2836(03)00243-2     Document Type: Article

References (98)

1. Philipsen S., Suske G. A tale of three fingers: the family of mammalian Sp/XKLF transcription factors. Nucl. Acids Res. 27:1999;2991-3000.
2. Suske G. The Sp-family of transcription factors. Gene. 238:1999;291-300.
3. Black A.R., Black J.D., Azizkhan-Clifford J. Sp1 and krüppel-like factor family of transcription factors in cell growth regulation and cancer. J. Cell. Physiol. 188:2001;143-160.
4. Choo Y., Klug A. Physical basis of a protein-DNA recognition code. Curr. Opin. Struct. Biol. 7:1997;117-125.
5. Wolfe S.A., Greisman H.A., Ramm E.I., Pabo C.O. Analysis of zinc fingers optimized via phage display: evaluating the utility of a recognition code. J. Mol. Biol. 285:1999;1917-1934.
6. Kadonaga J.T., Jones K.A., Tjian R. Promoter specific activation of RNA polymerase II by Sp1. Trends Biochem. Sci. 11:1986;20-23.
7. Liu C., Calogero A., Ragona G., Adamson E., Mercola D. EGR-1, the reluctant suppression factor. Crit. Rev. Oncol. 7:1996;101-125.
8. Christy B., Nathans D. DNA binding site of the growth factor-inducible protein Zif268. Proc. Natl Acad. Sci. USA. 86:1989;8737-8741.
9. Khachigian L.M., Lindner V., Williams A.J., Collins T. Egr-1-induced endothelial gene expression: a common theme in vascular injury. Science. 271:1996;1427-1431.
10. Matera A.G., Ward D.C. Localization of the human Sp1 transcription factor gene to 12q13 by fluorescence in situ hybridization. Genomics. 17:1993;793-794.
11. Le Beau M.M., Espinosa R. III, Neuman W.L., Stock W., Roulston D., Larson R.A., et al. Cytogenetic and molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases. Proc. Natl Acad. Sci. USA. 90:1993;5484-5488.
12. Horrigan S.K., Arbieva Z.H., Xie H.Y., Kravarusic J., Fulton N.C., Naik H., et al. Delineation of a minimal interval and identification of 9 candidates for a tumor suppressor gene in malignant myeloid disorders on 5q31. Blood. 95:2000;2372-2377.
13. Huang R.-P., Liu C., Fan Y., Mercola D., Adamson E. Egr-1 negatively regulates human tumor cell growth via the DNA-binding domain. Cancer Res. 55:1995;5054-5062.
14. Liu C., Adamson E., Mercola D. Transcription factor EGR-1 suppresses the growth and transformation of human HT-1080 fibrosarcoma cells by induction of transforming growth factor β1. Proc. Natl Acad. Sci. USA. 93:1996;11831-11836.
15. Rauscher F.J. III. The WT1 Wilms tumor gene product: a developmentally regulated transcription factor in the kidney that functions as a tumor suppressor. FASEB J. 7:1993;896-903.
16. Nakagama H., Heinrich G., Pelletier J., Housman D.E. Sequence and structural requirements for high-affinity DNA binding by the WT1 gene product. Mol. Cell. Biol. 15:1995;1489-1498.
17. Scharnhorst V., Dekker P., van der Eb A.J., Jochemsen A.G. Physical interaction between Wilms tumor 1 and p73 proteins modulates their functions. J. Biol. Chem. 275:2000;10202-10211.
18. Cohen H.T., Bossone S.A., Zhu G., McDonald G.A., Sukhatme V.P. Sp1 is a critical regulator of the Wilms' tumor-1 gene. J. Biol. Chem. 272:1997;2901-2913.
19. Wang Z., Qiu Q., Enger K.T., Deuel T.F. A second transcriptionally active DNA-binding site for the Wilms tumor gene product, WT1. Proc. Natl Acad. Sci. USA. 90:1993;8896-8900.
20. Swirnoff A.H., Milbrandt J. DNA-binding specificity of NGFI-A and related zinc finger transcription factors. Mol. Cell. Biol. 15:1995;2275-2287.
21. Madden M.J., Morrow C.S., Nakagawa M., Goldsmith M.E., Fairchild C.R., Cowan K.H. Identification of 5′ and 3′ sequences involved in the regulation of transcription of the human mdr1 gene in vivo. J. Biol. Chem. 268:1993;8290-8297.
22. Ambudkar S.V., Dey S., Hrycyna C.A., Ramachandra M., Pastan I., Gottesman M.M. Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu. Rev. Pharmacol. Toxicol. 39:1999;361-398.
23. Abolhoda A., Wilson A.E., Ross H., Danenberg P.V., Burt M., Scotto K.W. Rapid activation of MDR1 gene expression in human metastatic sarcoma after in vivo exposure to doxorubicin. Clin. Cancer Res. 5:1999;3352-3356.
24. Lehne G. P-glycoprotein as a drug target in the treatment of multidrug resistant cancer. Curr. Drug Targets. 1:2000;85-99.
25. Jin S., Gorfajn B., Faircloth G., Scotto K.W. Ecteinascidin 743, a transcription-targeted chemotherapeutic that inhibits MDR1 activation. Proc. Natl Acad. Sci. USA. 97:2000;6775-6779.
26. Scotto K.W., Johnson R.A. Transcription of the multidrug resistance gene MDR1: a therapeutic target. Mol. Interventions. 1:2001;14-22.
27. Bartsevich V.V., Juliano R.L. Regulation of the MDR1 gene by transcriptional repressors selected using peptide combinatorial libraries. Mol. Pharmacol. 58:2000;1-10.
28. Manzanares I., Cuevas C., García-Nieto R., Marco E., Gago F. Advances in the chemistry and pharmacology of ecteinascidins, a promising new class of anticancer agents. Curr. Med. Chem.-Anti-Cancer Agents. 1:2001;257-276.
29. Sundseth R., MacDonald G., Ting J., King A.C. DNA elements recognizing NF-Y and Sp1 regulate the human multidrug-resistance gene promoter. Mol. Pharmacol. 51:1997;963-971.
30. Hu Z., Jin S., Scotto K.W. Transcriptional activation of the MDR1 gene by UV irradiation. Role of NF-Y and Sp1. J. Biol. Chem. 275:2000;2979-2985.
31. Cornwell M.M., Smith D.E. Sp1 activates the MDR1 promoter through one of two distinct G-rich regions that modulate promoter activity. J. Biol. Chem. 268:1993;19505-19511.
32. McCoy C., Smith D.E., Cornwell M.M. 12-O-tetradecanoylphorbol-13-acetate activation of the MDR1 promoter is mediated by EGR1. Mol. Cell. Biol. 15:1995;6100-6108.
33. McCoy C., McGee S.B., Cornwell M.M. The Wilms' tumor suppressor, WT1, inhibits 12-O-tetradecanoylphorbol-13-acetate activation of the multidrug resistance-1 promoter. Cell Growth Differ. 10:1999;377-386.
34. Nekludova L., Pabo C.O. Distinctive DNA conformation with enlarged major groove is found in Zn-finger-DNA and other protein-DNA complexes. Proc. Natl Acad. Sci. USA. 91:1994;6948-6952.
35. Pavletich N.P., Pabo C.O. Zinc finger-DNA recognition: crystal structure of a Zif268-DNA complex at 2.1 Å Science. 252:1991;809-817.
36. García-Nieto R., Manzanares I., Cuevas C., Gago F. Bending of DNA upon binding of ecteinascidin 743 and phthalascidin 650 studied by unrestrained molecular dynamics simulations. J. Am. Chem. Soc. 122:2000;7172-7182.
37. García-Nieto R., Manzanares I., Cuevas C., Gago F. Increased DNA binding specificity for antitumor ecteinascidin ET743 through protein-DNA interactions? J. Med. Chem. 43:2000;4367-4369.
38. Marco E., García-Nieto R., Mendieta J., Manzanares I., Cuevas C., Gago F. A 3·(ET743)-DNA complex that both resembles an RNA-DNA hybrid and mimics zinc finger-induced DNA structural distortions. J. Med. Chem. 45:2002;871-880.
39. Norberg J., Nilsson L. Molecular dynamics applied to nucleic acids. Acc. Chem. Res. 35:2002;465-472.
40. Cheatham T.E. III, Kollman P.A. Molecular dynamics simulation of nucleic acids. Annu. Rev. Phys. Chem. 51:2000;435-471.
41. Narayan V.A., Kriwacki R.W., Caradonna J.P. Structures of zinc finger domains from transcription factor Sp1. Insights into sequence-specific protein-DNA recognition. J. Biol. Chem. 272:1997;7801-7809.
42. 2 zinc finger proteins. Annu. Rev. Biophys. Biomol. Struct. 29:2000;183-212.
43. Desjarlais J.R., Berg J.M. Toward rules relating zinc finger protein sequences and DNA binding site preferences. Proc. Natl Acad. Sci. USA. 89:1992;7345-7349.
44. Jamieson A.C., Wang H., Kim S.H. A zinc finger directory for high-affinity DNA recognition. Proc. Natl Acad. Sci. USA. 93:1996;12834-12839.
45. Segal D.J., Dreier B., Beerli R.R., Barbas C.F. III. Toward controlling gene expression at will: selection and design of zinc finger domains recognizing each of the 5′-GNN-3′ DNA target sequences. Proc. Natl Acad. Sci. USA. 96:1999;2758-2763.
46. Isalan M., Choo Y., Klug A. Synergy between adjacent zinc fingers in sequence-specific DNA recognition. Proc. Natl Acad. Sci. USA. 94:1997;5617-5621.
47. Dreier B., Segal D.J., Barbas C.F. III. Insights into the molecular recognition of the 5′-GNN-3′ family of DNA sequences by zinc finger domains. J. Mol. Biol. 303:2000;489-502.
48. Segal D.J., Barbas C.F. III. Design of novel sequence-specific DNA-binding proteins. Curr. Opin. Chem. Biol. 4:2000;34-39.
49. Choo Y., Isalan M. Advances in zinc finger engineering. Curr. Opin. Struct. Biol. 10:2000;411-416.
50. Beerli R.R., Segal D.J., Dreier B., Barbas C.F. III. Toward controlling gene expression at will: specific regulation of the erbB-2/HER-2 promoter by using polydactyl zinc finger proteins constructed from modular building blocks. Proc. Natl Acad. Sci. USA. 95:1998;14628-14633.
51. Kuwahara J., Yonezawa A., Futamura M., Sugiura Y. Binding of transcription factor Sp1 to GC box DNA revealed by footprinting analysis: different contact of three zinc fingers and sequence recognition mode. Biochemistry. 32:1993;5994-6001.
52. Gidoni D., Dynan W.S., Tjian R. Multiple specific contacts between a mammalian transcription factor and its cognate promoters. Nature. 312:1984;409-413.
53. Nagaoka M., Sugiura Y. Distinct phosphate backbone contacts revealed by some mutant peptides of zinc finger protein Sp1: effect of protein-induced bending on DNA recognition. Biochemistry. 35:1996;8761-8768.
54. Letovsky J., Dynan W.S. Measurement of the binding of transcription factor Sp1 to a single GC box recognition sequence. Nucl. Acids Res. 17:1989;2639-2653.
55. Thiesen H.J., Bach C. Target detection assay (TDA): a versatile procedure to determine DNA binding sites as demonstrated on SP1 protein. Nucl. Acids Res. 18:1990;3203-3209.
56. Kriwacki R.W., Schultz S.C., Steitz T.A., Caradonna J.P. Sequence-specific recognition of DNA by zinc-finger peptides derived from the transcription factor Sp1. Proc. Natl Acad. Sci. USA. 89:1992;9759-9763.
57. Thiesen H.J., Schroder B. Amino acid substitutions in the SP1 zinc finger domain alter the DNA binding affinity to cognate SP1 target site. Biochem. Biophys. Res. Commun. 175:1991;333-338.
58. Sjøttem E., Andersen C., Johansen T. Structural and functional analyses of DNA bending induced by Sp1 family transcription factors. J. Mol. Biol. 267:1997;490-504.
59. Yokono M., Saegusa N., Matsushita K., Sugiura Y. Unique DNA binding mode of the N-terminal zinc finger of transcription factor Sp1. Biochemistry. 37:1998;6824-6832.
60. Rotheneder H., Geymayer S., Haidweger E. Transcription factors of the Sp1 family: interaction with E2F and regulation of the murine thymidine kinase promoter. J. Mol. Biol. 293:1999;1005-1015.
61. Berg J.M. Sp1 and the subfamily of zinc finger proteins with guanine-rich binding sites. Proc. Natl Acad. Sci. USA. 89:1992;11109-11110.
62. Nardelli J., Gibson T.J., Vesque C., Charnay P. Base sequence discrimination by zinc-finger DNA-binding domains. Nature. 349:1991;175-178.
63. Desjarlais J.R., Berg J.M. Use of a zinc-finger consensus sequence framework and specificity rules to design specific DNA binding proteins. Proc. Natl Acad. Sci. USA. 90:1993;2256-2260.
64. Nagaoka M., Shiraishi Y., Uno Y., Nomura W., Sugiura Y. Interconversion between serine and aspartic acid in the alpha helix of the n-terminal zinc finger of sp1: implication for general recognition code and for design of novel zinc finger peptide recognizing complementary strand. Biochemistry. 41:2002;8819-8825.
65. Choo Y. End effects in DNA recognition by zinc finger arrays. Nucl. Acids Res. 26:1998;554-557.
66. Thukral S.K., Morrison M.L., Young E.T. Alanine scanning site-directed mutagenesis of the zinc fingers of transcription factor ADR1: residues that contact DNA and that transactivate. Proc. Natl Acad. Sci. USA. 88:1991;9188-9192.
67. Won J., Yim J., Kim T.K. Sp1 and Sp3 recruit histone deacetylase to repress transcription of human telomerase reverse transcriptase (hTERT) promoter in normal human somatic cells. J. Biol. Chem. 277:2002;38230-38238.
68. Nagaoka M., Shiraishi Y., Sugiura Y. Selected base sequence outside the target binding site of zinc finger protein Sp1. Nucl. Acid Res. 29:2001;4920-4929.
69. Ciudad C.J., Morris A.E., Jeng C., Chasin L.A. Point mutational analysis of the hamster dihydrofolate reductase minimum promoter. J. Biol. Chem. 267:1992;3650-3656.
70. Packer M.J., Dauncey M.P., Hunter C.A. Sequence-dependent DNA structure: tetranucleotide conformational maps. J. Mol. Biol. 295:2000;85-103.
71. Uno Y., Matsushita K., Nagaoka M., Sugiura Y. Finger-positional change in three zinc finger protein Sp1: influence of terminal finger in DNA recognition. Biochemistry. 40:2001;1787-1795.
72. Bowers P.M., Schaufler L.E., Klevit R.E. A folding transition and novel zinc finger accessory domain in the transcription factor ADR1. Nature Struct. Biol. 6:1999;478-485.
73. Sun D., Hurley L.H. Cooperative bending of the 21-base-pair repeats of the SV40 viral early promoter by human Sp1. Biochemistry. 33:1994;9578-9587.
74. Shi Y., Berg J.M. DNA unwinding induced by zinc finger protein binding. Biochemistry. 35:1996;3845-3848.
75. Ikeda K., Nagano K., Kawakami K. Possible implications of Sp1-induced bending of DNA on synergistic activation of transcription. Gene. 136:1993;341-343.
76. Mastrangelo I.A., Courey A.J., Wall J.S., Jackson S.P., Hough P.V. DNA looping and Sp1 multimer links: a mechanism for transcriptional synergism and enhancement. Proc. Natl Acad. Sci. USA. 88:1991;5670-5674.
77. Miller J.C., Pabo C.O. Rearrangement of side-chains in a Zif268 mutant highlights the complexities of zinc finger-DNA recognition. J. Mol. Biol. 313:2001;309-315.
78. McCoy C., McGee S.B., Cornwell M.M. The Wilms' tumor suppressor, WT1, inhibits 12-O-tetradecanoylphorbol-13-acetate activation of the multidrug resistance-1 promoter. Cell Growth Differ. 10:1999;377-386.
79. Ackerman S.L., Minden A.G., Williams G.T., Bobonis C., Yeung C.Y. Functional significance of an overlapping consensus binding motif for Sp1 and Zif268 in the murine adenosine deaminase gene promoter. Proc. Natl Acad. Sci. USA. 88:1991;7523-7527.
80. Papanikolaou N.A., Sabban E.L. Ability of Egr1 to activate tyrosine hydroxylase transcription in PC12 cells. Cross-talk with AP-1 factors. J. Biol. Chem. 275:2000;26683-26689.
81. Kramer B., Meichle A., Hensel G., Charnay P., Kronke M. Characterization of an Krox-24/Egr-1-responsive element in the human tumor necrosis factor promoter. Biochim. Biophys. Acta. 1219:1994;413-421.
82. Udvadia A.J., Rogers K.T., Horowitz J.M. A common set of nuclear factors bind to promoter elements regulated by the retinoblastoma protein. Cell Growth Differ. 3:1992;597-608.
83. Moshier J.A., Skunca M., Wu W., Boppana S.M., Rauscher F.J. III, Dosescu J. Regulation of ornithine decarboxylase gene expression by the Wilms' tumor suppressor WT1. Nucl. Acids Res. 24:1996;1149-1157.
84. Khachigian L.M., Williams A.J., Collins T. Interplay of Sp1 and Egr-1 in the proximal platelet-derived growth factor A-chain promoter in cultured vascular endothelial cells. J. Biol. Chem. 270:1995;27679-27686.
85. Khachigian L.M., Lindner V., Williams A.J., Collins T. Egr-1-induced endothelial gene expression: a common theme in vascular injury. Science. 271:1996;1427-1431.
86. Liu C., Calogero A., Ragona G., Adamson E., Mercola D. EGR-1, the reluctant suppression factor. Crit. Rev. Oncol. 7:1996;101-125.
87. Cornell W.D., Cieplak P., Bayly C.I., Gould I.R., Merz K.M., Ferguson D.M., et al. A second generation force field for the simulation of proteins, nucleic acids, and organic molecules. J. Am. Chem. Soc. 117:1995;5179-5197.
88. Cheatham T.E., Cieplak P., Kollman P.A. A modified version of the Cornell et al. force field with improved sugar pucker phases and helical repeat. J. Biomol. Struct. Dynam. 16:1999;845-862.
89. Guex N., Diemand A., Peitsch M.C. Protein modelling for all. Trends Biochem. Sci. 24:1999;364-367.
90. Arnott S., Hukins D.W. Optimised parameters for A-DNA and B-DNA. Biochem. Biophys. Res. Commun. 47:1972;1504-1509.
91. Åqvist J. Ion-water interaction potentials derived from free energy perturbation simulations. J. Phys. Chem. 94:1990;8021-8024.
92. Jorgensen W.L., Chandrasekhar J., Madura J.D. Comparison of simple potential functions for simulating liquid water. J. Chem. Phys. 79:1983;926-935.
93. *log(N) method for computing Ewald sums. J. Chem. Phys. 98:1993;10089-10092.
94. Ryckaert J.P., Ciccoti G., Berendsen H.J.C. Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes. J. Comput. Phys. 23:1977;327-341.
95. Lavery R., Sklenar H. The definition of generalized helicoidal parameters and of axis curvature for irregular nucleic acids. J. Biomol. Struct. Dynam. 6:1988;63-91.
96. Dickerson R.E. DNA bending: the prevalence of kinkiness and the virtues of normality. Nucl. Acids Res. 26:1998;1906-1926.
97. Zhong Z.-D., Hammani K., Bae W.S., DeClerck Y.A. NF-Y and Sp1 cooperate for the transcriptional activation and cAMP response of human tissue inhibitor of metalloproteinases-2. J. Biol. Chem. 275:2000;18602-18610.
98. Nicolás M., Noé V., Jensen K.B., Ciudad C.J. Cloning and characterization of the 5′-flanking region of the human transcription factor Sp1 gene. J. Biol. Chem. 276:2001;22126-22132.